Search results for "ADE"
showing 10 items of 15269 documents
Kirjallinen readymade 1960-luvun Suomessa
2017
Artikkeli käsittelee readymade-taiteen ja löydettyjen teosten (found object, objet trouvé) vastineita 1960-luvun kotimaisessa kirjallisuudessa. Aineisto koostuu viiden tekijän – Väinö Kirstinän, Kari Aronpuron, Kalevi Lappalaisen, Eeva-Liisa Mannerin ja M. A. Nummisen – teksteistä. Kirjallisia readymadejä käytettiin aikakauden kirjallisuudessa rinnakkain muiden kokeellisten ja taiteidenvälisten menetelmien kanssa. Artikkeli selvittelee, minkälainen ilmiö kirjallinen readymade on toisaalta 1960-luvun kontekstissa, toisaalta laajemmassa kirjallisuushistoriallisessa kontekstissa? Miten se suhteutuu alkuperäisiin readymadeihin, miten Marcel Duchampin pohdinnat ja käsitteellistykset sopivat kirj…
CCDC 2131009: Experimental Crystal Structure Determination
2022
Related Article: Braulio M. Puerta Lombardi, Ethan R. Pezoulas, Roope A. Suvinen, Alexander Harrison, Zachary S. Dubrawski, Benjamin S. Gelfand, Heikki M. Tuononen, Roland Roesler|2022|Chem.Commun.|58|6482|doi:10.1039/D2CC01476A
CCDC 1479850: Experimental Crystal Structure Determination
2016
Related Article: Shuai Liu, Haofu Dai, Gamall Makhloufi, Christian Heering, Christoph Janiak, Rudolf Hartmann, Attila Mándi, Tibor Kurtán, Werner E. G. Müller, Matthias U. Kassack, Wenhan Lin, Zhen Liu, Peter Proksch|2016|J.Nat.Prod.|79|2332|doi:10.1021/acs.jnatprod.6b00473
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults
2022
International audience; Safe and effective vaccines against coronavirus disease 2019 (COVID-19) are essential for ending the ongoing pandemic. Although impressive progress has been made with several COVID-19 vaccines already approved, it is clear that those developed so far cannot meet the global vaccine demand alone. We describe a COVID-19 vaccine based on a replication-defective gorilla adenovirus expressing the stabilized prefusion severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein named GRAd-COV2. We assessed the safety and immunogenicity of a single-dose regimen of this vaccine in healthy younger and older adults to select the appropriate dose for each age group…
How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy—a GIMEMA MPN…
2020
Since early 2020, the SARS-CoV-2 pandemic has a massive impact on health care systems worldwide. Patients with malignant diseases are assumed to be at increased risk for a worse outcome of SARS-CoV-2 infection, and therefore, guidance regarding prevention and management of the infection as well as safe administration of cancer-therapy is required. Here, we provide recommendations for the management of patients with malignant disease in the times of COVID-19. These recommendations were prepared by an international panel of experts and then consented by the EHA Scientific Working Group on Infection in Hematology. The primary aim is to enable clinicians to provide optimal cancer care as safely…
Dual Careers of Athletes During COVID-19 Lockdown
2021
This study aimed to investigate the student-athletes' capability to face the academic, sport, and social challenges during the coronavirus disease 2019 (COVID-19) lockdown and to disclose novel aspects of dual careers. A 32-item online survey encompassing demographic characteristics, sport and university engagement, support and dual-career benefits, physical activity, sitting time, and the time deemed necessary to recover the previous level of performance was developed. Four hundred sixty-seven student-athletes (males: 57%, females: 43%) from 11 countries, competing in 49 different sports (individual: 63.4%, team: 36.6%) at regional (17.5%), national (43.3%), and international (39.2%) level…
Eosinophil count in coronavirus disease 2019: more doubts than answers
2020
COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey
2020
Impact of the COVID-19 pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study
2021
N/A